Oliver Eng, MD, is a double board-certified surgeon and surgical oncologist who focuses on the treatment of cancers in the abdomen, and in particular, cancers that have spread to the peritoneum, the membrane that lines the abdominal cavity. He specializes in complex cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC) for locally advanced and metastatic cancers which have disseminated in the abdomen. HIPEC entails delivering high-dose heated chemotherapy in the operating room after surgical removal of visible disease, and is effective in different types of cancers.

Dr. Eng treats a variety of abdominal cancers and is skilled at minimally invasive robotic approaches for gastrointestinal and hepatobiliary malignancies, which enables the removal of tumors through small incisions. He also has expertise in the management of sarcomas, neuroendocrine tumors, metastatic cancers to the liver and malignant bowel obstructions.

Dr. Eng has published numerous peer-reviewed manuscripts in journals, including JAMA Surgery and Annals of Surgical Oncology. His research centers on better understanding the molecular and immunologic characteristics of peritoneal tumors, as well as optimizing outcomes and care for cancer patients. His work has been presented nationally and internationally, and he is the principal investigator or co-investigator on multiple clinical trials. He has co-authored many book chapters and serves as a reviewer for a variety of scientific journals.